FIGURE

Fig. 4

ID

ZDB-FIG-231102-19

Publication

Zisi et al., 2022 - Small Molecule-mediated Disruption of Ribosome Biogenesis Synergizes With FGFR Inhibitors to Suppress Glioma Cell Growth

Other Figures

All Figure Page

Back to All Figure Page

Fig. 4

High-throughput screen reveals compound classes that synergize with BMH-21. A172 cells were treated with 482 compounds in 5 concentrations, +/−BMH-210.15 for 72 h. (A) Data analysis and hit selection pipeline. (1) Compound ranking based on %δAUC. Cell viability (%DMSO) for each compound (y-axis) when combined with DMSO or BMH-210.15, as well as the %δAUC; horizontal broken lines indicate DMSO/TMZ controls. (2) Ranked compounds assigned into 3 groups (A–C) based on dose-response profiles indicated by brackets. (3) Synergistic compounds validation (Group B). Hits shown in pie charts, classified based on clinical stage and MoA; final-lead compounds shown with their MoA., and (4) Reevaluation of the 70 monotherapy hits (MoA classification pie chart). (B) A172 Cell viability (72 h treatment) and (C) Cas3/7-positive nuclei (48 treatment) with final synergistic pairs. (D) Luminescence from zebrafish 72 hpf-embryos (48 h-treatment). VEH mean value = 100%luminescence.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Neuro Oncol.